Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Explore scenarios where incorporating mutual funds into an index-based portfolio can improve diversification and adaptability.
24,945 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Investors are turning to PepsiCo for steady income as the 3.9% yield still looks like a safe-haven amid volatile mark...
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
A sharp global copper crunch boosts Freeport-McMoRan as the leading domestic copper king. Investors eye FCX for cash ...
Credo Technology rides a surge in AI infrastructure demand, but the path to $500 by 2030 hinges on durable revenue gr...
As gray divorce cases rise, financial planners warn a simple 50/50 split of retirement accounts often undercuts long-...
The White House is clear: there will be no pardon for Bankman-Fried, even as he engages in a high-profile social medi...
Broadcom is trading around $315, down about 9% year-to-date, as analysts push a $454 12-month target on accelerating ...
Trump acknowledges a philosophical difference with his VP on Iran, while markets react to the evolving policy landsca...
Capgemini’s strategy chief says the idea that AI will eliminate consultants is overstated, arguing transformation wor...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
Costco crossed the $1,000 mark in early May 2026, prompting fresh debate about selling in May—even for blue-chip equi...